Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

Rapport | 2022
la réduction des méfaits, les obstacles et les facilitateurs, le régime juridique / l'application de la loi
Report | 2022
Harm reduction, Barriers and enablers, Justice system/law enforcement
Webpage | 2022
Illegal drugs, Drug checking

Since the discovery of its anti-addictive properties by Howard S. Lotsof in 1962, ibogaine has been used experimentally to treat substance use disorders (SUD), especially those involving opioids.

Original research | 2022
About PWUD, Hallucinogens/psychedelics, Illegal drugs

Fentanyl is a highly lipophilic mu opioid receptor agonist increasingly found in heroin and other drug supplies that is contributing to marked increases in opioid-related overdose and may be compli

Original research | 2022
About PWUD, Withdrawal, Drug checking, Transitions in care/treatment

To assess the risk of opioid-related adverse events following opioid initiation among adults with versus without intellectual and developmental disability (IDD).

Original research | 2022
Chronic pain, Mental health

In 2000, the Portuguese minority socialist government decriminalised the possession and consumption of drugs.

Commentary | 2022
Decriminalization/legalization, Policy/Regulatory, Advocacy

Among veterans in care reporting opioid use, we investigated the association between ceasing opioid use on subsequent reduction in report of other substance use and improvements in pain, anxiety, a

Original research | 2023
About PWUD, Chronic pain, Mental health, Outcomes

The purpose of this literature review is to identify and summarize the evidence base on the associations between parental incarceration (PI) and subsequent drug use in the United States.

Lit review | 2022
Justice system/law enforcement, About PWUD

The potential misapplication of current opioid prescribing policies remains understudied and may have substantial adverse implications for patient safety.

Original research | 2023
About prescribers, Policy/Regulatory, Chronic pain

We examined post-release OAT discontinuation in a cohort of men who engaged in approximately monthly injecting drug use (IDU) prior to imprisonment in Victoria, Australia.

Original research | 2023
About PWUD, Justice system/law enforcement, Indigenous, Substitution/OAT

The recent publication of a national guideline and quality standards in Canada have provided clinicians with new, evidence-based recommendations on safe, appropriate opioid use.

Original research | 2022
About prescribers, Clinical guidance, Chronic pain

Our study aimed to understand why people start to use drugs, why they continue to use, what motivates them to continue to use or to seek treatment, and why individuals maintain recovery or return t

Original research | 2022
About PWUD, Stigma, Mental health, Barriers and enablers, Illegal drugs

In the context of rising concurrent stimulant use among people with opioid use disorder, this study aims to investigate the impact of stimulant use disorder on opioid agonist treatment dispensation

Original research | 2022
About PWUD, Stimulants, Substitution/OAT, Justice system/law enforcement

Acamprosate and naltrexone, evidence-based pharmacotherapies for alcohol use disorder (AUD), are publicly covered by the Ontario Drug Benefit (ODB) programs; however, their availability has changed

Original research | 2023
Policy/Regulatory, About prescribers, Outcomes
Guide or handbook | 2021
Wrap-around services, Housing, Harm reduction
Rapport | 2022
à propos des pharmaciens, les guides de pratique clinique, l'hésitation des prescripteurs

The Veterans Health Administration (VHA) implemented the Stratification Tool for Opioid Risk Mitigation (STORM) to reduce the risk of serious adverse events (SAE) among patients with opioid analges

Original research | 2022
Outcomes, Mortality, Policy/Regulatory, About PWUD, About prescribers

Refine Your Search